FreeCast (Direct Listing) (NASDAQ:CAST – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday. FreeCast (Direct Listing) Price Performance NASDAQ:CAST opened at $4.50 on Friday. FreeCast has a 12 month low of $1.88 and a 12 month high […]

Blink Charging (NASDAQ:BLNK – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Blink Charging in a report on Friday, January 9th. One investment analyst has […]

Torm (NASDAQ:TRMD – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Separately, Evercore reiterated an “outperform” rating and issued a $34.00 price objective on shares of Torm in a research report on Thursday, February 26th. […]

SEALSQ (NASDAQ:LAES – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. Other analysts also recently issued research reports about the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SEALSQ in a report on […]

Phunware (NASDAQ:PHUN – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Sunday. Several other research firms also recently issued reports on PHUN. HC Wainwright restated a “neutral” rating and issued a $2.00 price objective on shares of Phunware […]

Context Therapeutics (NASDAQ:CNTX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Sunday. A number of other research analysts have also weighed in on the stock. Weiss Ratings reissued a “sell (d-)” […]

Structure Therapeutics (NASDAQ:GPCR – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday. GPCR has been the topic of a number of other reports. Stifel Nicolaus upped their price objective on Structure Therapeutics from $50.00 to $90.00 […]

Janux Therapeutics (NASDAQ:JANX – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Several other analysts have also recently weighed in on the stock. Wedbush reissued an “outperform” rating and issued a $45.00 price objective (down from […]

Astec Industries (NASDAQ:ASTE – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. Several other research analysts also recently weighed in on the stock. Zacks Research upgraded shares of Astec Industries from a “hold” rating to […]